查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1507198

MCED（多種癌症早期檢測）市場、佔有率、規模、趨勢、行業分析報告、預測，2024-2032年

Multi Cancer Early Detection Market Share, Size, Trends, Industry Analysis Report Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，預計到2032年，全球MCED（多種癌症早期檢測）市場規模將達到39.3479億美元。本研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

由於基因組學、生物技術和人工智慧的進步，MCED（多種癌症早期檢測）市場迅速發展。該市場致力於診斷測試的開發和商業化，這些測試可以從單一樣本中檢測多種癌症類型，通常使用血液測試等非侵入性方法。其目的是在早期可治療階段發現癌症，改善患者治療效果並降低醫療費用。

有幾個因素推動了多種癌症早期檢測市場的成長。首先，全球癌症發生率不斷上升，以及人們對早期檢測益處的認識不斷提高，刺激了對創新診斷解決方案的需求。據世界衛生組織（WHO）表示，癌症是全球頭號死亡原因，預計未來20年新發病例將增加約 60%。其次，基因組學和分子生物學的技術進步開發敏感且特異的生物標記，可以及早發現癌症。公司利用這些進步來開發多種癌症篩檢測試，這些測試可以納入常規臨床實踐。

此外，公共和私營部門對研發的大量投資加快該領域的創新步伐。各國政府和衛生組織也日益支持早期檢測舉措，認識到其拯救生命和減少長期醫療保健支出的潛力。此外，個人化醫療的普及和向預防性護理的轉變推動 MCED（多種癌症早期檢測）測試整合到更廣泛的篩檢計劃中。綜合考慮這些驅動因素，MCED（多癌症早期檢測）市場預計在未來幾年將顯著成長，並改變癌症診斷和患者護理。

MCED（多種癌症早期檢測）市場報告亮點

由於液體活檢的研究不斷增加，液體活檢領域預計將以最快的年複合成長率成長。

由於個人化醫療意識不斷增強以及對負擔得起的服務的需求不斷成長，診斷實驗室行業預計將快速成長

由於癌症患者數量不斷增加以及提高生存率的需求不斷成長，預計亞太地區將出現顯著成長

目錄

第1章 簡介

第2章 執行摘要

第3章 研究方法

第4章 洞察全球 MCED（多種癌症早期檢測）市場

  • 行業概況
  • MCED（多發性癌症早期檢測）市場動態
    • 推動因素和機會
      • 多種癌症早期檢測（MCED）測試透過人工智慧整合改變癌症篩檢
      • 提高癌症檢出率
    • 抑制因素和挑戰
      • 圍繞 MCED（多種癌症早期檢測）檢測的潛在風險和不確定性
  • 波特五力分析
  • PESTLE分析
  • MCED（多種癌症早期檢測）產業的趨勢
  • 價值鏈分析
  • 新冠肺炎（COVID-19）影響分析

第5章 全球 MCED（多種癌症早期檢測）市場：依類型

  • 主要發現
  • 簡介
  • 液體活檢
  • 基因組，LDT
  • 其他

第6章 全球 MCED（多種癌症早期檢測）市場：依最終用戶

  • 主要發現
  • 簡介
  • 醫院
  • 診斷實驗室
  • 其他

第7章 全球 MCED（多種癌症早期檢測）市場：地區

  • 主要發現
  • 簡介
    • MCED（多種癌症早期檢測）市場評估：地區，2019-2032年
  • 北美
    • 北美：依最終使用者，2019-2032年
    • 北美：依類型，2019-2032年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依最終使用者，2019-2032年
    • 歐洲：依類型，2019-2032年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
  • 亞太地區
    • 亞太地區：依最終使用者，2019-2032年
    • 亞太地區：依類型，2019-2032年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
  • 中東、非洲
    • 中東和非洲：依最終用戶，2019-2032年
    • 中東、非洲：依類型，2019-2032年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
  • 拉丁美洲
    • 拉丁美洲：依最終使用者，2019-2032年
    • 拉丁美洲：依類型，2019-2032年
    • 墨西哥
    • 巴西
    • 阿根廷

第8章 競爭態勢

  • 擴張與收購分析
    • 擴張
    • 收購
  • 夥伴關係/協作/協定/揭露

第9章 公司簡介

  • Illumina, Inc.（GRAIL, LLC）
  • Exact Sciences Corp.
  • Foundation Medicine, Inc
  • AnchorDx
  • Guardant Health
  • Burning Rock Biotech Ltd
  • GENECAST
  • Beijing Lyman Juntai International Medical Technology Development Co
  • Freenome Holdings, Inc.
  • Elypta AB
Product Code: PM4952

The global multi cancer early detection market size is expected to reach USD 3,934.79 million by 2032, according to a new study by Polaris Market Research. The report "Multi Cancer Early Detection Market Size, Share & Trends Analysis Report, By Type (Liquid Biopsy, Gene Panel, LDT & Others), By End-use (Hospitals, Diagnostic Laboratories), By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The multi-cancer early detection market is rapidly evolving, driven by advances in genomics, biotechnology, and artificial intelligence. This market focuses on the development and commercialization of diagnostic tests capable of detecting multiple cancer types from a single sample, often using non-invasive methods such as blood tests. The aim is to identify cancer at an early, more treatable stage, improving patient outcomes and reducing healthcare costs.

Several factors are driving the growth of the multi-cancer early detection market. Firstly, the increasing global incidence of cancer, coupled with the rising awareness of the benefits of early detection, fuels demand for innovative diagnostic solutions. According to the World Health Organization, cancer is a leading cause of death worldwide, with new cases expected to rise by approximately 60% over the next two decades. Secondly, technological advancements in genomics and molecular biology have led to the development of highly sensitive and specific biomarkers that can detect cancer at very early stages. Companies are leveraging these advancements to create multi-cancer screening tests that can be integrated into routine clinical practice.

Additionally, substantial investments in research and development by both private and public sectors are accelerating the pace of innovation in this field. Governments and health organizations are also increasingly supporting early detection initiatives, recognizing their potential to save lives and reduce long-term healthcare expenditures. Furthermore, the growing adoption of personalized medicine and the shift towards preventive healthcare are encouraging the integration of multi-cancer early detection tests into broader health screening programs. Collectively, these driving factors position the multi-cancer early detection market for significant growth in the coming years, promising to transform cancer diagnostics and patient care.

Multi Cancer Early Detection Market Report Highlights

The liquid biopsy segment is anticipated to grow at the fastest CAGR, owing rise in research towards liquid biopsies

The diagnostic laboratories segment will grow with rapid pace, due to the increased awareness of personalized medicine, rise in demand for affordable services

APAC expected to witness substantial growth rate, due to rising number of cancer cases and rising need to increase survival rate

The global players include Illumina, Sciences Corp., Foundation Medicine, AnchorDxFreewomen, and Elypta

Polaris Market Research has segmented the Multi Cancer Early Detection Market report based on type, end use, and region:

Multi Cancer Early Detection, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Liquid Biopsy
  • Gene Panel, LDT & Others

Multi Cancer Early Detection End-use Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Diagnostic Laboratories
  • Other

Multi Cancer Early Detection, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Multi Cancer Early Detection Market Insights

  • 4.1. Multi Cancer Early Detection Market - Industry Snapshot
  • 4.2. Multi Cancer Early Detection Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Multi-Cancer Early Detection (MCED) Tests Transforming Cancer Screening with AI Integration
      • 4.2.1.2. Enhancing Cancer Detection Rates
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Potential Risks and Uncertainties Surrounding Multi-Cancer Early Detection Tests
  • 4.3. Porter's Five Forces Analysis<
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Multi Cancer Early Detection Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Multi Cancer Early Detection Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Multi Cancer Early Detection, by Type, 2019-2032 (USD Million)
  • 5.3. Liquid Biopsy
    • 5.3.1. Global Multi Cancer Early Detection Market, by Liquid Biopsy, by Region, 2019-2032 (USD Million)
  • 5.4. Gene Panel, LDT
    • 5.4.1. Global Multi Cancer Early Detection Market, by Gene Panel, LDT, by Region, 2019-2032 (USD Million)
  • 5.5. Others
    • 5.5.1. Global Multi Cancer Early Detection Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Multi Cancer Early Detection Market, by End User

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Global Multi Cancer Early Detection Market, by Hospitals, by Region, 2019-2032 (USD Million)
  • 6.4. Diagnostic Laboratories
    • 6.4.1. Global Multi Cancer Early Detection Market, by Diagnostic Laboratories, by Region, 2019-2032 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Multi Cancer Early Detection Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Multi Cancer Early Detection Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Multi Cancer Early Detection Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Multi Cancer Early Detection Market - North America
    • 7.3.1. North America: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
    • 7.3.2. North America: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.3.3. Multi Cancer Early Detection Market - U.S.
      • 7.3.3.1. U.S.: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.3.4. Multi Cancer Early Detection Market - Canada
      • 7.3.4.1. Canada: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • 7.4. Multi Cancer Early Detection Market - Europe
    • 7.4.1. Europe: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
    • 7.4.2. Europe: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.3. Multi Cancer Early Detection Market - UK
      • 7.4.3.1. UK: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.4. Multi Cancer Early Detection Market - France
      • 7.4.4.1. France: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.4.2. France: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.5. Multi Cancer Early Detection Market - Germany
      • 7.4.5.1. Germany: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.6. Multi Cancer Early Detection Market - Italy
      • 7.4.6.1. Italy: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.7. Multi Cancer Early Detection Market - Spain
      • 7.4.7.1. Spain: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.8. Multi Cancer Early Detection Market - Netherlands
      • 7.4.8.1. Netherlands: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.9. Multi Cancer Early Detection Market - Russia
      • 7.4.9.1. Russia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • 7.5. Multi Cancer Early Detection Market - Asia Pacific
    • 7.5.1. Asia Pacific: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.5.3. Multi Cancer Early Detection Market - China
      • 7.5.3.1. China: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.5.3.2. China: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.5.4. Multi Cancer Early Detection Market - India
      • 7.5.4.1. India: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.5.4.2. India: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.5.5. Multi Cancer Early Detection Market - Malaysia
      • 7.5.5.1. Malaysia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.5.6. Multi Cancer Early Detection Market - Japan
      • 7.5.6.1. Japan: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.5.7. Multi Cancer Early Detection Market - Indonesia
      • 7.5.7.1. Indonesia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.5.8. Multi Cancer Early Detection Market - South Korea
      • 7.5.8.1. South Korea: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • 7.6. Multi Cancer Early Detection Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.6.3. Multi Cancer Early Detection Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.6.4. Multi Cancer Early Detection Market - UAE
      • 7.6.4.1. UAE: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.6.5. Multi Cancer Early Detection Market - Israel
      • 7.6.5.1. Israel: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.6.6. Multi Cancer Early Detection Market - South Africa
      • 7.6.6.1. South Africa: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • 7.7. Multi Cancer Early Detection Market - Latin America
    • 7.7.1. Latin America: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.7.3. Multi Cancer Early Detection Market - Mexico
      • 7.7.3.1. Mexico: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.7.4. Multi Cancer Early Detection Market - Brazil
      • 7.7.4.1. Brazil: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.7.5. Multi Cancer Early Detection Market - Argentina
      • 7.7.5.1. Argentina: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Illumina, Inc. (GRAIL, LLC)
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Exact Sciences Corp.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Foundation Medicine, Inc
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. AnchorDx
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Guardant Health
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Burning Rock Biotech Ltd
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. GENECAST
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Beijing Lyman Juntai International Medical Technology Development Co
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Freenome Holdings, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Elypta AB
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development

List of Tables

  • Table 1 Global Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 2 Global Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 3 Multi Cancer Early Detection Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 4 North America: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 5 North America: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 6 U.S.: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 7 U.S.: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 8 Canada: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 9 Canada: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 10 Europe: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 11 Europe: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 12 UK: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 13 UK: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 14 France: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 15 France: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 16 Germany: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 17 Germany: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 18 Italy: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 19 Italy: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 20 Spain: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 21 Spain: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 22 Netherlands: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 23 Netherlands: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 24 Russia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 25 Russia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 26 Asia Pacific: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 27 Asia Pacific: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 28 China: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 29 China: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 30 India: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 31 India: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 32 Malaysia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 33 Malaysia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 34 Japan: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 35 Japan: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 36 Indonesia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 37 Indonesia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 38 South Korea: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 39 South Korea: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 40 Middle East & Africa: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 41 Middle East & Africa: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 42 Saudi Arabia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 43 Saudi Arabia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 44 UAE: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 45 UAE: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 46 Israel: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 47 Israel: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 48 South Africa: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 49 South Africa: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 50 Latin America: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 51 Latin America: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 52 Mexico: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 53 Mexico: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 54 Brazil: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 55 Brazil: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 56 Argentina: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 57 Argentina: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)

List of Figures

  • Figure 1 Global Multi Cancer Early Detection Market, 2019-2032 (USD Million)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by End User
  • Figure 7 Global Multi Cancer Early Detection Market, by End User, 2022 & 2032 (USD Million)
  • Figure 8 Market by Type
  • Figure 9 Global Multi Cancer Early Detection Market, by Type, 2022 & 2032 (USD Million)
  • Figure 10 Multi Cancer Early Detection Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 11 Strategic Analysis - Multi Cancer Early Detection Market